91 related articles for article (PubMed ID: 8603739)
1. Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells.
Lu H; Mabilat C; Yeh P; Guitton JD; Li H; Pouchelet M; Shoevaert D; Legrand Y; Soria J; Soria C
FEBS Lett; 1996 Feb; 380(1-2):21-4. PubMed ID: 8603739
[TBL] [Abstract][Full Text] [Related]
2. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.
Koolwijk P; van Erck MG; de Vree WJ; Vermeer MA; Weich HA; Hanemaaijer R; van Hinsbergh VW
J Cell Biol; 1996 Mar; 132(6):1177-88. PubMed ID: 8601593
[TBL] [Abstract][Full Text] [Related]
3. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T
Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor enhances the expression of urokinase receptor in human endothelial cells via protein kinase C activation.
Kroon ME; Koolwijk P; Vermeer MA; van der Vecht B; van Hinsbergh VW
Thromb Haemost; 2001 Feb; 85(2):296-302. PubMed ID: 11246551
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro.
Pepper MS; Ferrara N; Orci L; Montesano R
J Cell Sci; 1995 Jan; 108 ( Pt 1)():73-83. PubMed ID: 7537748
[TBL] [Abstract][Full Text] [Related]
9. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
[TBL] [Abstract][Full Text] [Related]
10. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
11. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.
Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R
Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853
[TBL] [Abstract][Full Text] [Related]
12. Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin.
Lu H; Yeh P; Guitton JD; Mabilat C; Desanlis F; Maury I; Legrand Y; Soria J; Soria C
FEBS Lett; 1994 Dec; 356(1):56-9. PubMed ID: 7988721
[TBL] [Abstract][Full Text] [Related]
13. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
[TBL] [Abstract][Full Text] [Related]
14. Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.
Koolwijk P; Kapiteijn K; Molenaar B; van Spronsen E; van der Vecht B; Helmerhorst FM; van Hinsbergh VW
J Clin Endocrinol Metab; 2001 Jul; 86(7):3359-67. PubMed ID: 11443212
[TBL] [Abstract][Full Text] [Related]
15. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
17. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.
Wilson AJ; Gibson PR
Gut; 2000 Jul; 47(1):105-11. PubMed ID: 10861271
[TBL] [Abstract][Full Text] [Related]
18. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.
Pepper MS; Mandriota SJ
Exp Cell Res; 1998 Jun; 241(2):414-25. PubMed ID: 9637783
[TBL] [Abstract][Full Text] [Related]
19. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R; Kumar S; Orci L; Pepper MS
Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
